spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  protein therapeutics 

 HSMN NewsFeed - 16 Dec 2021
Orna Therapeutics Expands Leadership Team with Key Executive Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2021
Biond Biologics Announces Closing of $15 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jul 2021
Lilly Announces Acquisition of Protomer Technologies
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Aug 2020
Haemonetics Clinical Study Results On A New, Personalized Approach To Plasma Collection To Be Presented At 2020 AABB Annual Meeting
Devices
 HSMN NewsFeed - 25 Jun 2020
Enterome Completes €46.3 Million ($52.6 Million) Financing to Progress the Clinical Development of Its Therapeutic Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 Feb 2020
Pharvaris Appoints Peng Lu, M.D., Ph.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Aug 2018
Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2018
Sutro Biopharma Collaborates with Merck to Develop Therapeutics for Cancer and Autoimmune Disorders
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 12 Jul 2018
Synthorx Expands Leadership Team with Three Key Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2018
Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin(TM) Cytokines
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Nov 2017
Laura Shawver, Ph.D., Appointed CEO of Synthorx
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Aug 2017
Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2017
Leading Protein Scientist Dr. Asya Grinberg Joins Dragonfly Therapeutics as Head of Biologics
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Feb 2017
Kamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Nov 2016
Synthorx Appoints Patrick J. Doyle as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2016
Kamada Announces Extension of GLASSIA(R) Supply and Distribution Agreement with Shire with Minimum $237 Million of Revenue for the Years 2017 to 2020
Biopharmaceuticals Distribution Licensing
 HSMN NewsFeed - 1 Sep 2016
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Aug 2016
Ambrx Closes $45M Round of Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Feb 2016
Amarantus Requests Rare Pediatric Disease Designation from US FDA for MANF in the Treatment of Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 19 Jan 2016
Akcea Therapeutics Appoints Louis St. L. O'Dea as Chief Medical Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 18 Dec 2015
European Commission Approves Amgen's IMLYGIC(TM) (talimogene laherparepvec) As First Oncolytic Immunotherapy In Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Dec 2015
Allena Pharmaceuticals Raises $53 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Sep 2015
Tunitas Therapeutics Closes $10 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 29 Sep 2015
Audentes Therapeutics Expands Senior Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Aug 2015
Omidria(R) Approved for Commercialization Throughout the European Union and Additional Countries
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 22 May 2015
Omidria(R) Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products for Human Use
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 21 May 2015
Jose-Carlos Gutiérrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2015
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 2 Feb 2015
FDA Approves New Dosing Option for CSL Behring's Hizentra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Nov 2014
Eleven Biotherapeutics Announces Additional Financing of $20 Million
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 30 Oct 2014
Omidria(TM) Granted Pass-Through Reimbursement Status from CMS
Biopharmaceuticals Ophthalmology Reimbursement
 HSMN NewsFeed - 10 Jul 2014
Jounce Therapeutics Appoints Richard Murray, Ph.D., to Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jun 2014
Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2014
Omeros Receives FDA Approval of Omidria(TM) for Use in Cataract and Other Intraocular Lens Replacement Procedures
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 24 Feb 2014
InVivo Therapeutics Names Thomas R. Ulich, MD as Its New Chief Scientific Officer
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 5 Feb 2014
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2013
Kamada Announces Appointment of Amir London as Senior Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2013
Omeros Hires Michael K. Inouye to Lead Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Sep 2013
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 3 Sep 2013
CSL Behring Announces FDA Approval of a 10 g (50 mL) Vial Size for Hizentra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jun 2013
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2013
Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2013
Acceleron Receives Two FDA Orphan Designations for ACE-536
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Feb 2013
CSL Behring Receives FDA Approval to Expand the Indication for Corifact(R)
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 24 Oct 2012
Sutro Biopharma Expands Senior Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Jun 2012
PRIMA Study Shows Treatment with Privigen(R) Improved Function in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2012
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2012
Sutro Closes $16.5 Million Second Tranche of Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 May 2012
Five Prime Therapeutics Announces the Promotion of Aron Knickerbocker to Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Mar 2012
CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery
Biopharmaceuticals Surgery
 HSMN NewsFeed - 29 Feb 2012
NPS Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Dec 2011
Acceleron Secures $30M Private Financing
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 16 Nov 2011
Allena Pharmaceuticals Launches with $15 Million Series A Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Sep 2011
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2011
Santarus and Pharming Announce Receipt of FDA Refusal to File Letter for RHUCIN Biologics License Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Feb 2011
Santarus and Pharming Announce Initiation of Phase IIIb Clinical Study with RHUCIN in Acute Hereditary Angioedema
Biopharmaceuticals
 HSMN NewsFeed - 28 Dec 2010
Pharming and Santarus announce submission of Rhucin Biologics License Application to FDA
Biopharmaceuticals
 HSMN NewsFeed - 28 Dec 2010
Pharming and Swedish Orphan Biovitrum announce first sales of Ruconest in Europe
Biopharmaceuticals
 HSMN NewsFeed - 20 Dec 2010
NovaDigm Therapeutics Appoints C. Boyd Clarke to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Dec 2010
Dr. Steve Kaldor Joins Furiex Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2010
Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Nov 2010
Sutro Biopharma Secures $36.5 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Nov 2010
OctoPlus Appoints Jan Hendrik Egberts as CEO
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 26 Oct 2010
aTyr Pharma Secures $23M Financing From Top Tier Venture Investor
Biopharmaceuticals Venture Captial
 HSMN NewsFeed - 13 Oct 2010
Cell Biosciences to Acquire Convergent Bioscience
Diagnostics Personalized Medicine Mergers & Acquisitions
 HSMN NewsFeed - 7 Oct 2010
Privigen(R) Demonstrates Efficacy and Tolerability Among Patients With Various Immunodeficiencies, Data Show
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2010
Data Support Hizentra(R) Efficacy, Safety After Dose-Equivalent Switch in Adult and Pediatric Patients with Primary Immunodeficiency
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2010
Study Demonstrates Safety and Efficacy of Subcutaneous Vivaglobin(R) as First-Line Therapy for Primary Immunodeficiency
Biopharmaceuticals
 HSMN NewsFeed - 16 Sep 2010
Itero Biopharmaceuticals Appoints Debanjan Ray to Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2010
Pharming signs commercialization agreement with Santarus for Rhucin(R) in North America
Biopharmaceuticals
 HSMN NewsFeed - 23 Aug 2010
Taligen Closes $10 Million Series B Financing Tranche
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Aug 2010
BioMarin Acquires ZyStor Therapeutics, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Jul 2010
Lilly to Acquire Alnara Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jun 2010
Zymeworks Closes $3.2 Million Round of Financing and Announces the Addition of Dr. Donald Drakeman to Its Board of Directors
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 17 Jun 2010
Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 17 Jun 2010
OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 7 Jun 2010
Grifols to Acquire Talecris Biotherapeutics Creating a World Leading Provider of Life-Saving Plasma Protein Therapies
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 May 2010
Dr. John Mendlein Joins aTyr Pharma as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2010
Taligen Announces Key Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2010
Taligen Appoints Industry Leader, John Maraganore, as Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2010
Auxilium Announces Promotion of Benjamin Del Tito Jr., Ph.D. to Executive Vice President, Regulatory Affairs and Project Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2010
Eleven Biotherapeutics Completes $35 Million Series A Funding to Advance Pipeline of Innovative Protein-Based Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Jan 2010
Alnara Pharmaceuticals Secures $35 Million in Series B Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Nov 2009
Alnara Pharmaceuticals Announces Appointment of Lee R. Brettman, M.D., FACP, to Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2009
Morphotek(R), Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Oct 2009
Facet Biotech's Board of Directors Recommends Stockholders Continue to Reject Biogen Idec's Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Sep 2009
Calypso Medical Closes $50 Million Venture Financing Round
Devices Oncology Venture Capital
 HSMN NewsFeed - 20 Aug 2009
Sutro Biopharma Announces Additions to Board of Directors and Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2009
aTyr Pharma Raises an Additional $12 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Jul 2009
Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jun 2009
Alios BioPharma, Inc. Closes $32 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Apr 2009
Prodarsan(R) granted Orphan Drug designation from FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Apr 2009
Synageva BioPharma Announces $30 Million Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Mar 2009
Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Feb 2009
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Feb 2009
Alios BioPharma, Inc. Completes First Closing of Series A Financing With Commitment of $24 MM From 3 Top-Tier Investors
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Feb 2009
Merck & Co., Inc. Acquires Biologic Manufacturing Capabilities and Developmental Follow-on Biologics Portfolio from Insmed
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 28 Jan 2009
BAROFOLD, INC. APPOINTS J. WILLIAM FREYTAG, Ph.D. AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2009
Anaphore, Inc. Announces $25 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jan 2009
Kawasaki Disease Treated with Plasma-Derived Therapy
Biopharmaceuticals
 HSMN NewsFeed - 30 Oct 2008
Alnara Pharmaceuticals, Inc. Secures $20 Million in Series A Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Sep 2008
Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Aug 2008
Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Jul 2008
PhiloGene, Inc. Announces that VEGFb(TM) has been Granted Orphan Drug Designation by the FDA for the Treatment of Advanced Melanoma
Biopharmaceuticals FDA Oncology
 HSMN NewsFeed - 2 Jul 2008
Bayer HealthCare and Maxygen Announce Hematology Agreement
Biopharmaceuticals Licensing Acquisitions
 HSMN NewsFeed - 4 Jun 2008
Battelle Ventures Broadens Life Sciences Portfolio; Creates NellOne Therapeutics, Inc., a Spinout from Oak Ridge National Laboratory
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 14 May 2008
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2008
Latona Announces the Acquistion of Patent Rights and Orphan Drug Status to Novel Late Stage Drug Compound for Juvenile and Adult Rheumatoid Arthritis
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Apr 2008
European Regulatory Agency Grants Orphan Status to Morphotek(R)'s Farletuzumab and MORAb-009
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 Apr 2008
Anaphore, Inc Receives $8M Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Mar 2008
Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Mar 2008
Pharming signs distribution agreement for Rhucin(R) in Turkey
Biopharmaceuticals Distribution
 HSMN NewsFeed - 20 Mar 2008
Pharming to receive Negative Opinion on European Marketing Authorization Application for Rhucin(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Mar 2008
Morphotek(R) Signs Exclusive Licensing Agreement for Anti-Cancer Antibody
Biopharmaceuticals Licensing
 HSMN NewsFeed - 26 Feb 2008
Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2008
Last Patient Enrolled In ATryn(R) Pivotal Study
Biopharmaceuticals
 HSMN NewsFeed - 5 Feb 2008
Altus Pharmaceuticals Announces Executive Management Changes; Altus Announces Resignation of Sheldon Berkle as President and CEO; Board Names Chairman of the Board, David D. Pendergast, Ph.D., as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jan 2008
FDA Approves ZymoGenetics' RECOTHROM(TM) Thrombin, topical (Recombinant)
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jan 2008
Nastech Appoints Bruce R. York as Interim Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2007
BioMimetic Therapeutics Reports Positive Clinical Results for GEM OS(R)1 in Canadian Foot and Ankle Fusion Study
Devices Orthopaedic
 HSMN NewsFeed - 4 Dec 2007
VistaGen Names Agustin de la Calle, Ph.D. as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2007
Inflazyme Pharmaceuticals Announces Closing of Transaction With Biolipox
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Nov 2007
Skyline Ventures Closes $350 Million Healthcare Fund
Venture Capital
 HSMN NewsFeed - 8 Nov 2007
Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2007
Altus Pharmaceuticals Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2007
Allozyne, Inc., Closes $30 Million Series B Financing and Appoints Meenu Chhabra as President and Chief Executive Officer
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 25 Oct 2007
Jeffrey D. Bloss, M.D., Joins Xencor as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2007
Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
Biopharmaceuticals Personnel Drug Delivery
 HSMN NewsFeed - 24 Sep 2007
Bristol-Myers Squibb to Acquire Adnexus Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Sep 2007
Inflazyme Pharmaceuticals Signs Asset Sale Agreement With Biolipox for a Potential Value of up to $11 Million, Plus a Potential Royalty Payment
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Sep 2007
Medtronic Makes Equity Investment in NanoCor Therapeutics, Inc.
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 30 Aug 2007
Pharming Presents Positive Results from European Phase III Trial of Rhucin(R)
Biopharmaceuticals
 HSMN NewsFeed - 13 Jul 2007
BioMimetic Therapeutics' Clinical Investigator Presents Positive Interim Data on U.S. and Canadian Foot and Ankle Clinical Trials
Devices Orthopaedic
 HSMN NewsFeed - 11 Jul 2007
Adnexus Therapeutics Appoints Martin Freed, MD as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jun 2007
Altus Pharmaceuticals Submits Investigational New Drug Application to Study ALTU-237 for the Treatment for Hyperoxalurias and the Potential Prevention of Kidney Stone Formation
Biopharmaceuticals
 HSMN NewsFeed - 19 Jun 2007
ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Jun 2007
Altus Pharmaceuticals Reacquires European Development and Commercialization Rights to ALTU-135
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 6 Jun 2007
Lewis T. 'Rusty' Williams, M.D., Ph.D. Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2007
BaroFold to Raise $12 Million in Private Placement
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 May 2007
Former Immunex Management Team Chosen to Head-Up CTI Subsidiary Aequus BioPharma, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2007
Altus Pharmaceuticals Initiates Phase III Clinical Trials of ALTU-135 for Cystic Fibrosis Patients with Pancreatic Insufficiency
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2007
Viron Therapeutics Appoints Claude Benedict, M.D. as New Senior Vice President, Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2007
OctoPlus Gains Full Rights to PolyActive Drug Delivery Technology From IsoTis
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 29 Mar 2007
Pharming Strengthens Organization for Commercial Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2007
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Mar 2007
Rincon Pharmaceuticals Appoints Dr. Peter B. Heifetz as Chief Scientific Officer, Drs. Jacqueline J. Johnson and Alan J. Lewis to Board of Directors, and Drs. Katherine S. Bowdish and Mich B. Hein to Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2007
Cangene receives an approvable letter from the FDA for human growth hormone
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Feb 2007
Bristol-Myers Squibb Company and Adnexus Therapeutics Announce Collaboration to Develop and Commercialize Innovative Oncology Compounds
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Feb 2007
VistaGen Therapeutics Names Dr. Matthew W. Kalnik as Executive Vice President
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 21 Feb 2007
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Feb 2007
Cell Therapeutics, Inc. (CTI) Spin-off to Use Proprietary Recombinant Genetic Technology to Develop Novel Biopharmaceuticals, Follow-on Biologics and to Deliver siRNA
Biopharmaceuticals
 HSMN NewsFeed - 25 Jan 2007
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS(R)1 to Treat Distal Radius Fractures
Devices Orthopaedic
 HSMN NewsFeed - 16 Jan 2007
Pharming Receives European Orphan Drug Designation
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Dec 2006
Altus Pharmaceuticals Enters into Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Products for Growth Hormone Deficient Patients
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Dec 2006
Altus Pharmaceuticals Appoints Bruce A. Leicher General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2006
Receptor BioLogix Names Four New Senior Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2006
BioMimetic Therapeutics Announces Positive Results Using GEM OS1(TM) Bone Graft in Foot/Ankle Fusions
Devices Orthopaedic
 HSMN NewsFeed - 7 Dec 2006
Xenon Enters Into Anemia Collaboration With Roche
Biopharmaceuticals
 HSMN NewsFeed - 30 Nov 2006
Concert Pharmaceuticals Raises $48.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Nov 2006
Adnexus Therapeutics Appoints Bruce A. Silver, MD, FACP as Medical Director
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Nov 2006
OctoPlus Grants Green Cross Corporation Exclusive Korean License to OP-145 for Chronic Middle ear Infection
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 Nov 2006
Altus Pharmaceuticals Appoints Shire Executive David Pendergast to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2006
Treatment of Diabetic Foot Ulcers to Be Addressed at Upcoming American Heart Association Meeting
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 1 Nov 2006
Schering-Plough Expanding Discovery Operations in Cambridge, Mass.
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2006
Pharming Shareholders Appoint Bruno Giannetti as Member of the Board of Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2006
BioMimetic Therapeutics Receives FDA Approval that Expands Manufacturing Capacity for GEM 21S(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Oct 2006
GTC Biotherapeutics and LFB Biotechnologies Enter Strategic Collaboration for Recombinant Plasma Proteins and Monoclonal Antibodies
Biopharmaceuticals
 HSMN NewsFeed - 27 Sep 2006
Trubion Announces Initiation of Phase IIb Clinical Trial of TRU-015 for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 27 Sep 2006
BioMimetic Therapeutics Adds Key Talent to Board of Directors
Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2006
NovaCardia Raises $48 Million in Series B
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 12 Sep 2006
Pharming Appoints Bruno Giannetti as Chief Operations Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2006
Adnexus Therapeutics Expands and Strengthens Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Aug 2006
Momenta Pharmaceuticals Announces Appointment of Craig A. Wheeler as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Aug 2006
Altus Pharmaceuticals Appoints Renato Fuchs, Ph.D., Senior Vice President, Manufacturing and Technical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Aug 2006
Cardium Acquires Excellarate Product Candidate for Chronic Diabetic Ulcers and Related Technology and Assets From Tissue Repair Company
Biopharmaceuticals Wound Care Acquisitions
 HSMN NewsFeed - 11 Aug 2006
Altus Pharmaceuticals Appoints John M. Sorvillo, Ph.D. as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2006
European Commission Approves ATryn(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 31 Jul 2006
Receptor BioLogix Acquires Late-Stage Cancer Drug from Aphton Corp.
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 28 Jul 2006
Pharming Receives Fast Track Designation from US FDA for Recombinant Human C1 Inhibitor
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jul 2006
Altus Pharmaceuticals Updates Plans for Initiation of Phase III Clinical Trials for ALTU-135 and ALTU-238
Biopharmaceuticals
 HSMN NewsFeed - 21 Jul 2006
Pharming Submits Marketing Authorisation Application for Recombinant Human C1 Inhibitor in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Jul 2006
Concert Pharmaceuticals, Inc., a Small Molecule Pharmaceutical Company, Announces Financing of its Series A Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Jul 2006
Nastech Pharmaceutical Company Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Jun 2006
Receptor BioLogix Names Thomas A. Glaze Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2006
Altus Pharmaceuticals Announces Positive Results from Phase II Study in Growth Hormone Deficient Patients with Once-Per-Week Growth Hormone
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2006
Morphotek Announces Orphan Drug Status Granted for MORAb-003, A Monoclonal Antibody for the Treatment of Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Jun 2006
First AdNectin Therapeutic, CT-322, Clears FDA IND Review to Start Clinical Trials
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Jun 2006
Compound Therapeutics Becomes Adnexus Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 8 Jun 2006
Altus Pharmaceuticals Hires Dr. Burkhard Blank as Senior Vice President of Medicine, Regulatory Affairs and Project Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2006
ATryn(R) Receives CHMP Recommendation to Grant Market Authorization
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 May 2006
Seattle Genetics Names Pamela Trail, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2006
ConjuChem Announces New Executive Vice President, Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2006
Maxygen Achieves Milestone in Alliance with Roche for Factor VIIa Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2006
Altus Pharmaceuticals Appoints Lauren Sabella Vice President, Commercial Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2006
Phyton Biotech, Inc., a DFB Pharmaceuticals Affiliate, Signs Licensing Agreement with DiAthegen LLC to Commercialize Growth Hormone Receptor Antagonist That Treats Acromegaly, Cancer, Diabetes
Biopharmaceuticals
 HSMN NewsFeed - 6 Apr 2006
Pfizer to Expand Neuroscience Research With Acquisition of Biotech Company Rinat Neuroscience
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Mar 2006
PHARMING ANNOUNCES ACQUISITION OF DNAGE B.V.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Feb 2006
QLT's Board of Directors Appoints Robert Butchofsky as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2006
Pharming Announces Strategic Agreement Valued at US $30 Million
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 91

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 91 additional stories matching:
protein therapeutics
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.